N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
- PMID: 7662668
- DOI: 10.1021/bi00034a021
N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
Abstract
Advanced glycation end products (AGEs) and glycoxidation products are formed during Maillard or browning reactions between sugars and proteins and are implicated in the pathophysiology of aging and the complications of diabetes. To determine the structure of AGEs, antibodies were prepared to protein browned by incubation with glucose and used in ELISA assays to measure AGEs formed in model reactions between bovine serum albumin (BSA) or N alpha-acetyllysine and glucose, fructose, or glyoxal. AGEs were formed from glucose and fructose only under oxidative conditions, but from glyoxal under both oxidative and antioxidative conditions. Gel permeation chromatographic analysis indicated that a similar AGE was formed in reactions of N alpha-acetyllysine with glucose, fructose, and glyoxal and that this AGE co-eluted with authentic N alpha-acetyl-N epsilon-(carboxymethyl)lysine. Amino acid analysis of AGE proteins revealed a significant content of N epsilon-(carboxymethyl)lysine (CML). In ELISA assays using polyclonal antibodies against AGE proteins, CML-BSA (approximately 25 mol of CML/mol of BSA), prepared by chemical modification of BSA, was a potent inhibitor of the recognition of AGE proteins and of AGEs in human lens proteins. We conclude that AGEs are largely glycoxidation products and that CML is a major AGE recognized in tissue proteins by polyclonal antibodies to AGE proteins.
Similar articles
-
Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.Biochim Biophys Acta. 2000 Sep 29;1481(2):255-64. doi: 10.1016/s0167-4838(00)00133-3. Biochim Biophys Acta. 2000. PMID: 11018716
-
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.Mol Med. 2000 Feb;6(2):114-25. Mol Med. 2000. PMID: 10859028 Free PMC article.
-
N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.Biochemistry. 1996 Jun 18;35(24):8075-83. doi: 10.1021/bi9530550. Biochemistry. 1996. PMID: 8672512
-
New biomarkers of Maillard reaction damage to proteins.Nephrol Dial Transplant. 1996;11 Suppl 5:41-7. doi: 10.1093/ndt/11.supp5.41. Nephrol Dial Transplant. 1996. PMID: 9044306 Review.
-
Advanced glycation endproducts in food and their effects on health.Food Chem Toxicol. 2013 Oct;60:10-37. doi: 10.1016/j.fct.2013.06.052. Epub 2013 Jul 16. Food Chem Toxicol. 2013. PMID: 23867544 Review.
Cited by
-
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.Am J Pathol. 2003 Apr;162(4):1123-37. doi: 10.1016/S0002-9440(10)63909-0. Am J Pathol. 2003. PMID: 12651605 Free PMC article.
-
Effect of glycation on alpha-crystallin structure and chaperone-like function.Biochem J. 2007 Dec 1;408(2):251-8. doi: 10.1042/BJ20070989. Biochem J. 2007. PMID: 17696877 Free PMC article.
-
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.Diabetologia. 2007 Jul;50(7):1409-17. doi: 10.1007/s00125-007-0687-z. Epub 2007 May 4. Diabetologia. 2007. PMID: 17479244
-
Role of the Maillard reaction in diabetes mellitus and diseases of aging.Drugs Aging. 1996 Aug;9(2):69-77. doi: 10.2165/00002512-199609020-00001. Drugs Aging. 1996. PMID: 8820792 Review.
-
Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats.Diabetol Metab Syndr. 2014 May 20;6:57. doi: 10.1186/1758-5996-6-57. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 24920962 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources